Close Menu

NEW YORK ─ Oxford Immunotec Global on Monday announced that it has entered into a long-term agreement to supply its T-Spot.TB test and associated accessories to the Stop TB Partnership - Global Drug Facility (GDF).

The announcement follows the inclusion of the Oxford Immunotec T-Spot.TB test, a blood test for TB screening, in the GDF's diagnostics catalog for the detection of tuberculosis (TB) infection.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.